Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

[ANCA and anti-MBG double-positive vasculitis: An update on the clinical and therapeutic specificities and comparison with the two eponymous vasculitis].

Philip R, Dumont A, Le Mauff B, Martinet M, Martin Silva N, de Boysson H, Lobbedez T, Aouba A, Deshayes S.

Rev Med Interne. 2020 Jan;41(1):21-26. doi: 10.1016/j.revmed.2019.10.334. Epub 2019 Dec 12. French.

PMID:
31839271
2.

HLA-Class II Artificial Antigen Presenting Cells in CD4+ T Cell-Based Immunotherapy.

Couture A, Garnier A, Docagne F, Boyer O, Vivien D, Le-Mauff B, Latouche JB, Toutirais O.

Front Immunol. 2019 May 17;10:1081. doi: 10.3389/fimmu.2019.01081. eCollection 2019. Review.

3.

Increased frequencies of circulating and tumor-resident Vδ1+ T cells in patients with diffuse large B-cell lymphoma.

Reboursiere E, Gac AC, Garnier A, Salaun V, Reman O, Pham AD, Cabrera Q, Khoy K, Vilque JP, Fruchart C, Chantepie S, Johnson-Ansah H, Macro M, Cheze S, Benabed K, Mear JB, Troussard X, Damaj G, Le Mauff B, Toutirais O.

Leuk Lymphoma. 2018 Jan;59(1):187-195. doi: 10.1080/10428194.2017.1321751. Epub 2017 May 31.

PMID:
28562153
4.

In Vivo Cysteinyl Leukotriene Release in Allergic and Nonallergic Immediate Hypersensitivity Reactions during Anesthesia.

Laroche D, Léturgie P, Mariotte D, Ollivier Y, Hanouz JL, Le Mauff B, Parienti JJ.

Anesthesiology. 2017 May;126(5):834-841. doi: 10.1097/ALN.0000000000001600.

PMID:
28301407
5.

Is it relevant to screen young women hospitalized in psychiatric department for neuropsychiatric systemic lupus erythematosus (NPSLE)?: A prospective study of 100 psychiatric inpatients.

Audemard-Verger A, Comby E, Nathou C, Sultan A, Frémont M, Baldolli A, Trumier LS, Marzloff V, Le Mauff B, Manuzak J, Dollfus S, Bienvenu B.

Medicine (Baltimore). 2016 Nov;95(47):e5288.

6.

Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.

Dupont B, Mariotte D, Dugué AE, Clarisse B, Grellard JM, Babin E, Chauffert B, Dakpé S, Moldovan C, Bouhier-Leporrier K, Reimund JM, Di Fiore F, Zanetta S, Mailliez A, Do P, Peytier A, Galais MP, Florescu C, Schott R, Le Mauff B, Gervais R.

Br J Clin Pharmacol. 2017 Mar;83(3):623-631. doi: 10.1111/bcp.13140. Epub 2016 Oct 24.

7.

Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells.

Garnier A, Hamieh M, Drouet A, Leprince J, Vivien D, Frébourg T, Le Mauff B, Latouche JB, Toutirais O.

Immunol Cell Biol. 2016 Aug;94(7):662-72. doi: 10.1038/icb.2016.25. Epub 2016 Feb 29.

PMID:
26924643
8.

Prevalence of monoclonal gammopathy of undetermined significance (MGUS) among farmers involved in open field farming and/or cattle breading in France.

Lecluse Y, Comby E, Mariotte D, Tual S, Le Mauff B, Lebailly P, Gauduchon P.

Leuk Lymphoma. 2016 Jul;57(7):1727-30. doi: 10.3109/10428194.2015.1113277. Epub 2015 Dec 21. No abstract available.

PMID:
26689498
9.

B-cell subpopulations in children: National reference values.

Duchamp M, Sterlin D, Diabate A, Uring-Lambert B, Guérin-El Khourouj V, Le Mauff B, Monnier D, Malcus C, Labalette M, Picard C.

Immun Inflamm Dis. 2014 Nov;2(3):131-40. doi: 10.1002/iid3.26. Epub 2014 Jul 31.

10.

Risk factors associated with hypersensitivity reactions to cetuximab: anti-cetuximab IgE detection as screening test.

Dupont B, Mariotte D, Clarisse B, Galais MP, Bouhier-Leporrier K, Grellard JM, Le Mauff B, Reimund JM, Gervais R.

Future Oncol. 2014 Nov;10(14):2133-40. doi: 10.2217/fon.14.153.

PMID:
25471028
11.

Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.

Colliou N, Picard D, Caillot F, Calbo S, Le Corre S, Lim A, Lemercier B, Le Mauff B, Maho-Vaillant M, Jacquot S, Bedane C, Bernard P, Caux F, Prost C, Delaporte E, Doutre MS, Dreno B, Franck N, Ingen-Housz-Oro S, Chosidow O, Pauwels C, Picard C, Roujeau JC, Sigal M, Tancrede-Bohin E, Templier I, Eming R, Hertl M, D'Incan M, Joly P, Musette P.

Sci Transl Med. 2013 Mar 6;5(175):175ra30. doi: 10.1126/scitranslmed.3005166.

12.

Immediate hypersensitivity to platelet concentrate: allergic or not?

Mariotte D, Bazin A, Da Silva Costa-Aze V, Pottier V, Samba D, Vergnaud MC, Comby E, Le Mauff B, Laroche D.

Transfus Med. 2013 Apr;23(2):136-7. doi: 10.1111/tme.12007. Epub 2013 Jan 29. No abstract available.

PMID:
23356776
13.

Gene transfer of human CD40Ig does not prevent rejection in a non-human primate kidney allotransplantation model.

Angin M, Poirier N, Dilek N, Le Guiner C, Toromanoff A, Blancher A, Cherel Y, Deschamps JY, Tillou X, Renaudin K, Minault D, Hervouet J, Blancho G, Vanhove B, Anegon I, Le Mauff B.

Transpl Immunol. 2012 Dec;27(4):139-45. doi: 10.1016/j.trim.2012.10.004. Epub 2012 Oct 23.

PMID:
23098770
14.

Eosinophilic fasciitis with paroxysmal nocturnal hemoglobinuria.

de Boysson H, Chèze S, Chapon F, Le Mauff B, Auzary C, Geffray L.

Joint Bone Spine. 2013 Mar;80(2):208-10. doi: 10.1016/j.jbspin.2012.07.008. Epub 2012 Sep 19.

PMID:
22999899
15.

CD49d expression as a promising biomarker to monitor natalizumab efficacy.

Defer G, Mariotte D, Derache N, Toutirais O, Legros H, Cauquelin B, Le Mauff B.

J Neurol Sci. 2012 Mar 15;314(1-2):138-42. doi: 10.1016/j.jns.2011.10.005. Epub 2011 Nov 1.

PMID:
22050952
16.

Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis.

Mariotte D, Dupont B, Gervais R, Galais MP, Laroche D, Tranchant A, Comby E, Bouhier-Leporrier K, Reimund JM, Le Mauff B.

MAbs. 2011 Jul-Aug;3(4):396-401. Epub 2011 Jul 1.

17.

Stroke and the immune system: from pathophysiology to new therapeutic strategies.

Macrez R, Ali C, Toutirais O, Le Mauff B, Defer G, Dirnagl U, Vivien D.

Lancet Neurol. 2011 May;10(5):471-80. doi: 10.1016/S1474-4422(11)70066-7. Review.

PMID:
21511199
18.

Functional occurrence of the interaction of tissue plasminogen activator with the NR1 Subunit of N-methyl-D-aspartate receptors during stroke.

Macrez R, Bezin L, Le Mauff B, Ali C, Vivien D.

Stroke. 2010 Dec;41(12):2950-5. doi: 10.1161/STROKEAHA.110.592360. Epub 2010 Oct 21.

PMID:
20966414
19.

Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance.

Li XL, Ménoret S, Bezie S, Caron L, Chabannes D, Hill M, Halary F, Angin M, Heslan M, Usal C, Liang L, Guillonneau C, Le Mauff B, Cuturi MC, Josien R, Anegon I.

J Immunol. 2010 Jul 15;185(2):823-33. doi: 10.4049/jimmunol.1000120. Epub 2010 Jun 11.

20.

Promises and obstacles for the blockade of CD40-CD40L interactions in allotransplantation.

Li XL, Ménoret S, Le Mauff B, Angin M, Anegon I.

Transplantation. 2008 Jul 15;86(1):10-5. doi: 10.1097/TP.0b013e31817c4b97. Review.

PMID:
18622269
21.

CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.

Guillonneau C, Hill M, Hubert FX, Chiffoleau E, Hervé C, Li XL, Heslan M, Usal C, Tesson L, Ménoret S, Saoudi A, Le Mauff B, Josien R, Cuturi MC, Anegon I.

J Clin Invest. 2007 Apr;117(4):1096-106.

22.

Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation.

Martin C, Plat M, Nerriére-Daguin V, Coulon F, Uzbekova S, Venturi E, Condé F, Hermel JM, Hantraye P, Tesson L, Anegon I, Melchior B, Peschanski M, Le Mauff B, Boeffard F, Sergent-Tanguy S, Neveu I, Naveilhan P, Soulillou JP, Terqui M, Brachet P, Vanhove B.

Transgenic Res. 2005 Aug;14(4):373-84.

PMID:
16201404
23.
24.

CTLA4Ig adenoviral gene transfer induces long-term islet rat allograft survival, without tolerance, after systemic but not local intragraft expression.

Laumonier T, Potiron N, Boeffard F, Chagneau C, Brouard S, Guillot C, Soulillou JP, Anegon I, Le Mauff B.

Hum Gene Ther. 2003 Apr 10;14(6):561-75.

PMID:
12718766
25.

Adenovirus-mediated expression of human CD55 or CD59 protects adult porcine islets from complement-mediated cell lysis by human serum.

Schmidt P, Goto M, Le Mauff B, Anegon I, Korsgren O.

Transplantation. 2003 Mar 15;75(5):697-702.

PMID:
12640312
26.

Rapid failure of pig islet transplantation in non human primates.

Cantarovich D, Blancho G, Potiron N, Jugeau N, Fiche M, Chagneau C, Letessier E, Boeffard F, Loth P, Karam G, Soulillou JP, Le Mauff B.

Xenotransplantation. 2002 Jan;9(1):25-35.

PMID:
12005101
27.

Adenovirus-mediated cytokine gene transfer in heart allograft transplantation.

Guillot C, David A, Coathalem H, Froud D, Tesson L, Moullier P, Le Mauff B, Usal C, Soulillou JP, Cuturi MC, Anegon I.

Biochem Soc Trans. 1999 Dec;27(6):864-9. No abstract available.

PMID:
10830118
28.

Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.

Guillot C, Mathieu P, Coathalem H, Le Mauff B, Castro MG, Tesson L, Usal C, Laumonier T, Brouard S, Soulillou JP, Lowenstein PR, Cuturi MC, Anegon I.

J Immunol. 2000 May 15;164(10):5258-68.

29.

Gene therapy in transplantation in the year 2000: moving towards clinical applications?

Guillot C, Le Mauff B, Cuturi MC, Anegon I.

Gene Ther. 2000 Jan;7(1):14-9. Review.

30.

Intact pancreatic islet function despite humoral xenorecognition in the pig-to-monkey combination.

Mirenda V, Le Mauff B, Boeffard F, Cassard A, Jugeau N, Soulillou JP, Anegon I.

Transplantation. 1998 Dec 15;66(11):1485-95.

PMID:
9869090
31.

The role of adhesion molecules in ischaemia-reperfusion injury of renal transplants.

Hourmant M, Vasse N, le Mauff B, Soulillou JP.

Nephrol Dial Transplant. 1997 Dec;12(12):2485-7. Review. No abstract available.

PMID:
9430838
32.

Adenovirus-mediated gene transfer in rat liver of interleukin 4 but not interleukin 10 produces severe acute hepatitis.

David A, Chetritt J, Coupel-Clauce H, Tesson L, Cassard A, Blancho G, Charreau B, Sigalla J, Buzelin F, Le Mauff B, Soulillou JP, Anegon I.

Cytokine. 1997 Nov;9(11):818-29.

PMID:
9367542
33.

Adenovirus-mediated gene transfer into isolated mouse adult pancreatic islets: normal beta-cell function despite induction of an anti-adenovirus immune response.

Sigalla J, David A, Anegon I, Fiche M, Huvelin JM, Boeffard F, Cassard A, Soulillou JP, Le Mauff B.

Hum Gene Ther. 1997 Sep 1;8(13):1625-34.

PMID:
9322095
34.

Improvement of adult porcine islet recovery by early collagenase injection and low temperature digestion.

Mirenda V, Le Mauff B, Huvelin JM, Sigalla J, Auget JL, Soulillou JP.

Transplant Proc. 1997 Jun;29(4):2265. No abstract available.

PMID:
9193619
35.

Intact pig pancreatic islet function in the presence of human xenoreactive natural antibody binding and complement activation.

Mirenda V, Le Mauff B, Cassard A, Huvelin JM, Boeffard F, Faivre A, Soulillou JP, Anegon I.

Transplantation. 1997 May 27;63(10):1452-62.

PMID:
9175810
36.

In vitro and in vivo gene transfer in the rat: characterization of recombinant adenoviral vectors for rat interleukin-4 or interleukin-10 cDNA.

David A, Cassard A, Tesson L, Blancho G, Sigalla J, Charreau B, Godfrin Y, Smit H, Le Mauff B, Soulillou JP, Anegon I.

Transplant Proc. 1997 May;29(3):1750-1. No abstract available.

PMID:
9142259
37.

Pig pancreatic islet xenografts in a B-cell-deficient mouse model.

Mirenda V, Sigalla J, Fiche M, Thibaudeau K, Huvelin JM, Soulillou JP, Le Mauff B.

Transplant Proc. 1997 Feb-Mar;29(1-2):762-3. No abstract available.

PMID:
9123514
38.

Anti-CD4 MoAb therapy in kidney transplantation--a pilot study in early prophylaxis of rejection.

Dantal J, Ninin E, Hourmant M, Boeffard F, Cantarovich D, Giral M, Wijdenes J, Soulillou JP, Le Mauff B.

Transplantation. 1996 Nov 27;62(10):1502-6.

PMID:
8958279
39.

Xenoreactivity in the pig islet to human combination: feasibility of adenovirus-mediated gene transfer into pig islets.

Mirenda V, Charreau B, Sigalla J, Cassard A, Huvelin JM, David A, Soulillou JP, Le Mauff B, Anegon I.

Transplant Proc. 1996 Apr;28(2):808-10. No abstract available.

PMID:
8623410
40.

A dose-searching trial of an anti-LFA1 monoclonal antibody in first kidney transplant recipients.

Le Mauff B, Le Meur Y, Hourmant M, Debray M, Boeffard F, Alberici G, Soulillou JP, Scherrmann JM.

Kidney Int Suppl. 1996 Jan;53:S44-50.

PMID:
8770990
41.

Screening of a pig cDNA expression library with human serum in order to identify new xenoantigens.

Guérif F, Anegon I, le Mauff B, Soulillou JP, Pourcel C.

Transplant Proc. 1995 Aug;27(4):2491. No abstract available.

PMID:
7652900
42.

Anti-LFA-1 adhesion molecule monoclonal antibody in prophylaxis of human kidney allograft rejection.

Le Mauff B, Hourmant M, Le Meur Y, Dantal J, Cantarovich D, Caudrelier P, Alberici G, Soulillou JP.

Transplant Proc. 1995 Feb;27(1):865-6. No abstract available.

PMID:
7879210
43.

Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis.

Charreau B, Cassard A, Tesson L, Le Mauff B, Blanchard D, Lublin D, Soulillou JP, Anegon I.

Transplant Proc. 1995 Feb;27(1):336-7. No abstract available.

PMID:
7533404
44.

Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.

Charreau B, Cassard A, Tesson L, Le Mauff B, Navenot JM, Blanchard D, Lublin D, Soulillou JP, Anegon I.

Transplantation. 1994 Dec 15;58(11):1222-9.

PMID:
7527603
45.

Rat interleukin-2 immunoglobulin M fusion proteins are cytotoxic in vitro for cells expressing the IL-2 receptor and can abolish cell-mediated immunity in vivo.

Bogers WM, Lang F, Parker KE, Le Mauff B, Anegon I, Jacques Y, Soulillou JP.

Transplantation. 1994 Oct 27;58(8):932-9.

PMID:
7940738
46.

Administration of an anti-CD11a monoclonal antibody in recipients of kidney transplantation. A pilot study.

Hourmant M, Le Mauff B, Le Meur Y, Dantal J, Cantarovich D, Giral M, Caudrelier P, Albericci G, Soulillou JP.

Transplantation. 1994 Aug 15;58(3):377-80. No abstract available.

PMID:
8053064
47.

Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. II. Results after a second kidney transplantation.

Hourmant M, Le Mauff B, Cantarovich D, Dantal J, Baatard R, Denis M, Jacques Y, Karam G, Soulillou JP.

Transplantation. 1994 Jan;57(2):204-7.

PMID:
8310508
48.

Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. I. Results after combined pancreas and kidney transplantation.

Cantarovich D, Le Mauff B, Hourmant M, Dantal J, Baatard R, Denis M, Jacques Y, Karam G, Paineau J, Soulillou JP.

Transplantation. 1994 Jan;57(2):198-203.

PMID:
8310507
49.

Anti-interleukin 2 monoclonal antibody following simultaneous pancreatic and kidney transplantation: a randomized trial vs rabbit antithymocyte globulin.

Cantarovich D, Hourmant M, Dantal J, Baatard R, Le Mauff B, Jacques Y, Paineau J, Murat A, Soulillou JP.

Transplant Proc. 1993 Feb;25(1 Pt 2):1366. No abstract available.

PMID:
8442143
50.

Soluble interleukin 2 receptor (Tac chain) is not a reliable marker in kidney transplant recipient monitoring.

Trochu JN, Denis M, Auget JL, Giral M, Jacques Y, Soulillou JP, Le Mauff B.

Transpl Int. 1992 Jul;5(3):145-50.

PMID:
1325148

Supplemental Content

Loading ...
Support Center